Breaking News
Otolith Labs Announces $20 Million Series A Financing
“Otolith Labs, a medical technology company developing noninvasive wearable medical devices for the treatment of vestibular disorders, announced the closing of a $20 million Series A financing round. Building on prior investments from businessman Mark Cuban and leading ENT physicians, the proceeds will be used to support the company’s ongoing clinical programs, anticipated FDA approval, and the first commercial launch of a prescription wearable device for the treatment of chronic vertigo.”
In The News
Otolith Labs Rounds Out Executive Team with Hiring of Chief Clinical Officer
Kevin Franck, PhD, MBA appointed as Otolith Labs’ Chief Clinical Officer.
Mark Cuban-Backed Otolith Labs Just Raised Another $20M
Technical.ly interviews Otolith’s CEO Sam Owen about the pressing need for a new treatment option for chronic vertigo.
Otolith Labs is Proud to Sponsor VeDa
The Vestibular Disorder Association provides educational and support resources to people suffering from chronic vertigo and vestibular disorders.
Increased Bone Conducted Vibration Reduces Motion Sickness
Results from a study testing bone conductive vibrations proved the device decreases nausea from motion sickness.
Otolith Expands Leadership Team with CCO and New Board Member
Otolith appointed Dan Wagner as Chief Commercial Officer and Raphael Michel to Otolith’s Board of Directors.
Business Insider Interviews Otolith CEO Sam Owen About Series A Financing
Otolith’s CEO Sam Owen sat down with Insider to discuss Otolith’s $20 million Series A financing.
Selected as Top Five Finalist for the MedTech Innovator Execution Award Competition
The selection was made during the pre-conference virtual live stream on September 22, 2021.
D.C. Biotech is Raising Millions to Advance Medical Device for Vertigo
CEO Sam Owen discusses Otolith Labs usage of investor funding and the companies journey the past few years.
Deals Of The Week: Otolith Raised $20 Million In Series A Financing Round
Forbes features Otolith Labs’ $20 million Series A financing in “Deals Of The Week” for the week of Sept. 7, 2022.
Otolith Labs Finds Footing With $20M For Vertigo-Treating Wearable
Fierce Medtech discusses Otolith Labs’ Series A financing and the clinical development of Otolith technology.
NASA iTech 2020 Cycle 1 Winner
Through NASA’s iTech initiative, the agency discovers and assesses technologies that could help it accomplish future missions. Otolith Labs was one of the three winning teams in 2020.
MedTech Innovator Selects Otolith in Top 50 Medtech Startups
MedTech innovator unveils top 50 medtech startups selected for Annual showcase and accelerator, which includes Otolith Labs.
Otolith Receives Breakthrough Device Designation from FDA
Otolith Labs announces closing of $3.3 Million in seed funding, as well as receiving “Breakthrough Device” Designation from FDA.
Otolith Receives ISO 13485 Certification for Medical Devices Quality Management Systems from BSI
This is an important milestone for medical device companies.
Otolith Labs Interviewed on This Week In Hearing Episode
Dr. Robert Traynor interviews Otolith CEO and CSO on This Week In Hearing, presented by Hearing Health & Technology Matters.
Development of Therapeutic Headband for Vertigo Sufferers
Washington Business Journal talks about Otolith Labs’ plan for FDA approval and the funding necessary to get there.
Otolith Labs Rounds Out Executive Team with Hiring of Chief Clinical Officer
Kevin Franck, PhD, MBA appointed as Otolith Labs’ Chief Clinical Officer.
Otolith Expands Leadership Team with CCO and New Board Member
Otolith appointed Dan Wagner as Chief Commercial Officer and Raphael Michel to Otolith’s Board of Directors.
Deals Of The Week: Otolith Raised $20 Million In Series A Financing Round
Forbes features Otolith Labs’ $20 million Series A financing in “Deals Of The Week” for the week of Sept. 7, 2022.
Otolith Receives Breakthrough Device Designation from FDA
Otolith Labs announces closing of $3.3 Million in seed funding, as well as receiving “Breakthrough Device” Designation from FDA.
Mark Cuban-Backed Otolith Labs Just Raised Another $20M
Technical.ly interviews Otolith’s CEO Sam Owen about the pressing need for a new treatment option for chronic vertigo.
Business Insider Interviews Otolith CEO Sam Owen About Series A Financing
Otolith’s CEO Sam Owen sat down with Insider to discuss Otolith’s $20 million Series A financing.
Otolith Labs Finds Footing With $20M For Vertigo-Treating Wearable
Fierce Medtech discusses Otolith Labs’ Series A financing and the clinical development of Otolith technology.
Otolith Receives ISO 13485 Certification for Medical Devices Quality Management Systems from BSI
This is an important milestone for medical device companies.
Otolith Labs is Proud to Sponsor VeDa
The Vestibular Disorder Association provides educational and support resources to people suffering from chronic vertigo and vestibular disorders.
Selected as Top Five Finalist for the MedTech Innovator Execution Award Competition
The selection was made during the pre-conference virtual live stream on September 22, 2021.
NASA iTech 2020 Cycle 1 Winner
Through NASA’s iTech initiative, the agency discovers and assesses technologies that could help it accomplish future missions. Otolith Labs was one of the three winning teams in 2020.
Otolith Labs Interviewed on This Week In Hearing Episode
Dr. Robert Traynor interviews Otolith CEO and CSO on This Week In Hearing, presented by Hearing Health & Technology Matters.
Increased Bone Conducted Vibration Reduces Motion Sickness
Results from a study testing bone conductive vibrations proved the device decreases nausea from motion sickness.
D.C. Biotech is Raising Millions to Advance Medical Device for Vertigo
CEO Sam Owen discusses Otolith Labs usage of investor funding and the companies journey the past few years.
MedTech Innovator Selects Otolith in Top 50 Medtech Startups
MedTech innovator unveils top 50 medtech startups selected for Annual showcase and accelerator, which includes Otolith Labs.
Development of Therapeutic Headband for Vertigo Sufferers
Washington Business Journal talks about Otolith Labs’ plan for FDA approval and the funding necessary to get there.
Recognition
Recognition
Medtech Innovator Accelerator
Halcyon Incubator
NASA iTech 2020 Cycle 1 Winner
200 Massachusetts Ave NW, Floor 7, Washington, DC 20001
© 2024 Otolith Labs, Inc.